Medicine-Based Evidence in Congenital Heart Disease: How Artificial Intelligence Can Guide Treatment Decisions for Individual Patients
Built on the foundation of the randomized controlled trial (RCT), Evidence Based Medicine (EBM) is at its best when optimizing outcomes for homogeneous cohorts of patients like those participating in an RCT. Its weakness is a failure to resolve a clinical quandary: patients appear for care individua...
Guardado en:
Autores principales: | Jef Van den Eynde, Cedric Manlhiot, Alexander Van De Bruaene, Gerhard-Paul Diller, Alejandro F. Frangi, Werner Budts, Shelby Kutty |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a91857ed8d5485e89f290738d055af5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Left ventricular vortex analysis by high-frame rate blood speckle tracking echocardiography in healthy children and in congenital heart disease
por: Pietro Marchese, et al.
Publicado: (2021) -
Pain in adults with congenital heart disease - An international perspective
por: Allison Leibold, et al.
Publicado: (2021) -
How to read a published clinical trial: a practical guide for clinicians
por: Mohamad B Sonbol, et al.
Publicado: (2020) -
Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
por: Maarja Maser, et al.
Publicado: (2021) -
Trials
Publicado: (2006)